Dry Eye Disease

• CLINICAL_TRIALS withdrawal · 2025-12-10
  Clinical Trial Update: A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease [Phase 3]

  A Phase 3 study evaluating the long-term safety of a fixed-dose combination of lifitegrast and perfluorohexyloctane for dry eye disease has …

• CLINICAL_TRIALS withdrawal · 2023-12-18
  Clinical Trial Update: Tear Film Markers in Dry Eye Syndrome [Phase 4]

  A Phase 4 clinical trial on tear film markers in dry eye syndrome was withdrawn.

• CLINICAL_TRIALS withdrawal · 2019-05-17
  Clinical Trial Update: Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease [Phase 4]

  A Phase 4 clinical trial investigating the effects of Xiidra on closed-eye tear film leukocytes in dry eye disease was withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-03-18
  Clinical Trial Update: A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® [Phase 4]

  Phase IV randomized, investigator-masked trial evaluating whether Loteprednol etabonate 0.5% ophthalmic gel influences initiation of Restasi…

• CLINICAL_TRIALS withdrawal · 2014-11-14
  Clinical Trial Update: Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease [Phase 3]

  The Phase 3 trial assessing tear film thickness by optical coherence tomography in healthy subjects and in patients with dry eye disease has…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2013-10-11
  Clinical Trial Update: A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye [NA]

  A head-to-head clinical trial evaluating Artelac Rebalance versus Vismed for dry eye has been withdrawn.